CellCentric vs Lōkahi Therapeutics
CellCentric vs Lōkahi Therapeutics, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CellCentric is on 60/100 and Lōkahi Therapeutics on 57/100.
Where each one leads
CellCentric
- our overall score: 60/100 against 57/100
- agent readiness: 32/100 against 22/100
- headcount: 53 against 10
- funding raised: $375M against $63.0M
- LinkedIn following: 28,695 against 271
Lōkahi Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | CellCentric | Lōkahi Therapeutics |
|---|---|---|
| What it is | A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma. | A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Biotech | Biotechnology, Pharmaceuticals, Healthcare, Neurology |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2003 | 2017 |
| Headquarters | Cambridge, United Kingdom | La Jolla, USA |
| Status | Active | Inactive |
Size, funding and growth
| Measure | CellCentric | Lōkahi Therapeutics |
|---|---|---|
| Employees | 53 | 10 |
| Total funding | $375M | $63.0M |
| Latest round | Series D | Series B |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 28,695 | 271 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CellCentric | Lōkahi Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 57/100 |
| Traction | 57/100 | 49/100 |
| Team | 60/100 | 50/100 |
| Community | Not published | 15/100 |
| Search visibility | 44/100 | 34/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 35/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CellCentric | Lōkahi Therapeutics |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Not detected |
CellCentric vs Lōkahi Therapeutics: common questions
Which is better, CellCentric or Lōkahi Therapeutics?
On our 0-100 score CellCentric rates higher (60/100 against 57/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do CellCentric and Lōkahi Therapeutics compare on the numbers?
CellCentric leads on our overall score (60/100 against 57/100), agent readiness (32/100 against 22/100), headcount (53 against 10), funding raised ($375M against $63.0M), LinkedIn following (28,695 against 271).
Read the full CellCentric review and pricing or the Lōkahi Therapeutics review and pricing. You can also browse other CellCentric alternatives we track.